Showing results (161-170 of 218) with videos related to
Sort By:
Pageof 22
British Journal of Clinical Pharmacology|November 1, 1985
Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in healthP G Blain, J C Mucklow, M D Rawlins, et al.British Journal of Clinical Pharmacology|December 5, 2015
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.British Journal of Clinical Pharmacology|December 5, 2015
A multicentre open trial of labetalol in New ZealandG L Sanders, D M Davies, G M Gales, et al.European Journal of Clinical Pharmacology|December 18, 1978
Labetalol, a cross-over double blind controlled trialG L Sanders, P A Routledge, J G Rao, et al.European Journal of Clinical Pharmacology|March 11, 1977
Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertensionP A Routledge, L V Zrinzo, J G Rao, et al.British Journal of Clinical Pharmacology|January 1, 1979
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.American Journal of Nephrology|January 1, 1996
Monitoring of endothelial leucocyte adhesion molecule-1 in anti-neutrophil-cytoplasmic-antibody-positive vasculitisM Yaqoob, D C West, I McDicken, et al.Clinical Nephrology|May 16, 1998
Chronic bronchiectasis and anti-myeloperoxidase antibody related rapidly progressive necrotizing glomerulonephritisP Pai, R Rustom, J M Bone, et al.The Quarterly Journal of Medicine|May 1, 1992
Primary glomerulonephritis and hydrocarbon exposure: a case-control study and literature reviewM Yaqoob, G M Bell, D F Percy, et al.British Journal of Clinical Pharmacology|December 3, 1999
Attitudinal survey of voluntary reporting of adverse drug reactionsI A Eland, K J Belton, A C van Grootheest, et al.Pageof 22